{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-09-25",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "69413-558",
      "generic_name": "Mecamylamine Hydrochloride",
      "labeler_name": "Vyera Pharmaceuticals, LLC",
      "brand_name": "Vecamyl",
      "active_ingredients": [
        {
          "name": "MECAMYLAMINE HYDROCHLORIDE",
          "strength": "2.5 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "69413-558-40",
          "description": "100 TABLET in 1 BOTTLE (69413-558-40)",
          "marketing_start_date": "20130319",
          "sample": false
        }
      ],
      "listing_expiration_date": "20261231",
      "openfda": {
        "manufacturer_name": [
          "Vyera Pharmaceuticals, LLC"
        ],
        "rxcui": [
          "1298874",
          "1373008"
        ],
        "spl_set_id": [
          "0774cc48-7287-4093-91d6-9df41a81408a"
        ],
        "is_original_packager": [
          true
        ],
        "upc": [
          "0369413558400"
        ],
        "unii": [
          "4956DJR58O"
        ]
      },
      "marketing_category": "ANDA",
      "dosage_form": "TABLET",
      "spl_id": "a29db678-f591-44c7-be1c-3ec7ae06bea7",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20130319",
      "product_id": "69413-558_a29db678-f591-44c7-be1c-3ec7ae06bea7",
      "application_number": "ANDA204054",
      "brand_name_base": "Vecamyl",
      "pharm_class": [
        "Autonomic Ganglionic Blocker [EPC]",
        "Decreased Autonomic Ganglionic Activity [PE]"
      ]
    }
  ]
}